Certificate pursuant to SEBI Master Circular dated October 15, 2025
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biocon Limited has filed a quarterly compliance certificate for Commercial Papers (CPs) issued during the calendar year up to March 2026. The total CP issuance was Rs. 200 Crores. Two CP tranches were issued: one in December 2025 (Rs. 1800 Cr face value, matured March 2026) for acquisition of equity shares in subsidiary, and another in January 2026 (Rs. 200 Cr face value, matured March 2026) for redemption of debentures and acquisition of debentures issued by subsidiary. The company has certified that CP proceeds were used for stated purposes, listing conditions were adhered to, asset classification remains 'Standard', and there has been no material change in financial status affecting credit rating. Both CPs were fully bought back and payment obligations fulfilled by January 30, 2026.
This is a routine regulatory compliance filing confirming proper use of short-term borrowing funds. The certificate indicating 'Standard' asset classification and no adverse financial changes is neutral to positive for investors, though the filing carries no material new information about company operations.